Methods for diagnosis and treatment of endometrial cancer
US9110064B2 · kind B2 · utility
0Cited by
28References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 28, 2011 |
| Grant date | Aug 18, 2015 |
| Priority date | — |
| Expiry date | Jun 5, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/10
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention discloses methods of using epithelial membrane protein 2 (EMP2) as a biomarker for stratification of endometrial premalignancy, diagnosing, staging and imaging of endometrial neoplasia. Further, methods for identifying pharmaceutical/therapeutic modalities are described, including compositions which modulate glycolipid-enriched lipid raft microdomains (GEMs).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.